Page 1 of Clinical Trials for ( Drug Cipro XR Ciprofloxacin AND BAYQ3939 ), 13 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Study in COPD (Chronic Obstructive Pulmonary Disease) Subjects to Investigate Safety, Tolerability, and Pharmacokinetics of Ciprofloxacin After Single Dose Inhalations of 50 mg and 75 mg Ciprofloxacin Inhalation Powder
Last Updated: October 31, 2011
Condition(s): Infection; Pulmonary Disease, Chronic Obstructive
2
Completed
Efficacy and Safety of CIPRO XR Versus CIPRO IR in Patients With Complicated Urinary Tract Infections
Last Updated: June 29, 2009
Condition(s): Urinary Tract Infection
3
Recruiting
Study to Characterize Lung Deposition, Pharmacokinetics, Safety and Tolerability of Single Inhalations of Radiolabeled Ciprofloxacin Dry Powder in Healthy Subjects and Patients With Chronic Lung Diseases
Last Updated: May 23, 2012
Condition(s): Respiratory System
4
Completed
Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common Uropathogens
Last Updated: June 25, 2009
Condition(s): Urinary Tract Infections
5
Completed
Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: February 15, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
6
Recruiting
A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia
Last Updated: May 18, 2012
Condition(s): Pneumonia, Bacterial
7
Completed
Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: June 14, 2011
Condition(s): Disease, Pulmonary
8
Completed
Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis
Last Updated: April 5, 2012
Condition(s): Bronchiectasis
9
Completed
BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis
Last Updated: June 19, 2009
Condition(s): Bacterial Infections
10
Completed
Cipro® XR in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections
Last Updated: June 16, 2009
Condition(s): Urinary Tract Infection
11
Completed
To Evaluate the Safety, Tolerability, Pulmonary Deposition, Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Inhale in Japanese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD; GOLD II-III)
Last Updated: May 23, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
12
Completed
Cipro Inhaler for Cystic Fibrosis Children Ages 6-12
Last Updated: November 20, 2011
Condition(s): Pseudomonas Infection
13
Completed
A Phase IV Study of Cipro XR in Uncomplicated UTI
Last Updated: June 16, 2009
Condition(s): Urinary Tract Infections

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Cipro+XR+Ciprofloxacin%2C+BAYQ3939

Page 1 of Clinical Trials for ( Drug Cipro XR Ciprofloxacin AND BAYQ3939 ), 13 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About